XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2010-01871
- Event Type
- Injury
- Date Received
- September 8, 2010
- Date of Event
- August 15, 2010
- Report Date
- August 15, 2010
- Manufacturer
- ABBOTT VASCULAR CLONMEL
- Product Code
- NIQ
- PMA / PMN Number
- P070015
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN
- Reporter Occupation
- OTHER
Narratives
(B)(4). DISSECTION IS A KNOWN ADVERSE EVENT AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED. THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MFR, DESIGN, OR LABELING. ALL STENT DELIVERY SYSTEMS ARE SUBJECTED TO A 100% VISUAL INSPECTION. IN ADDITION, A QUALITY CONTROL AUDIT INSPECTION IS USED TO VERIFY THE PRODUCT QUALITY.
DEVICE ISSUE: NONE. ADVERSE EVENT: DISSECTION REQUIRING INTERVENTION. TIME OF ADVERSE EVENT: DURING THE PROCEDURE. IT WAS REPORTED THAT DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY THE PHYSICIAN WAS STENTING THE OSTIAL TO MID LEFT ANTERIOR DESCENDING ARTERY (LAD) WITH A 2.75 MM X 28 MM XIENCE V. THERE WAS A DISSECTION OF THE MID LAD AT THE DISTAL EDGE OF THE XIENCE V DURING IMPLANTATION. REPORTEDLY, THE LESION WAS CALCIFIED. THE PHYSICIAN USED ANOTHER 2.75 MM X 12 MM XIENCE V AT THE MID LAD TO TREAT THE DISTAL EDGE DISSECTION. NO PT EFFECTS WERE REPORTED. NO ADDITIONAL INFO WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM | NIQ | ABBOTT VASCULAR CLONMEL | NA | 0012841 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 55 YR | Required Intervention | WHISPER ES GUIDE WIRE| JL4 GUIDE CATHETER |